CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Immune mechanisms in cerebral ischemic toleranceTime-Dependent Protection of CB2 Receptor Agonist in StrokeWhat we know and do not know about the cannabinoid receptor 2 (CB2)Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cellsBrain CB₂ Receptors: Implications for Neuropsychiatric Disorders.Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosisCannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats.Cannabinoids in experimental stroke: a systematic review and meta-analysis.Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Trisubstituted Sulfonamides: a New Chemotype for Development of Potent and Selective CB2 Receptor Inverse Agonists.Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injuryEffects of Cannabinoids on T-cell Function and Resistance to Infection.Craniula: A cranial window technique for prolonged imaging of brain surface vasculature with simultaneous adjacent intracerebral injection.The endocannabinoid system: an overview.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditionsUpdate on the role of cannabinoid receptors after ischemic stroke.A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10IV and IP administration of rhodamine in visualization of WBC-BBB interactions in cerebral vesselsThe kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injuryReduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression.The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.Modulating the endocannabinoid system in human health and disease--successes and failuresCannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrierCannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects.Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.
P2860
Q24633122-3AEB5BDE-6FE4-4CC1-B93E-EAE69049B89BQ27022067-D201949E-39AB-4AAD-9F5C-4687D8F4EB59Q27302924-36045667-80B4-41BA-84CF-02B15C8CAE48Q27686851-C8D1D58D-138F-49A7-AB56-F231B8DF8379Q33597201-A975C865-A5C2-4148-A460-545F88201058Q33664105-5B677CAA-1BCA-44B9-A2C3-FB402BB2A150Q33847549-8C9AC6AB-D995-4A73-9954-5799128281F6Q33947213-7ADD2054-AB38-48B8-9C49-F27D2008EB35Q34325190-CAAEAD60-FAFE-4896-A15C-F458E27920A7Q34452972-9D30BC5B-E80E-45AB-B64B-EF64F0E636D1Q34591087-54686E99-4359-4420-954B-3D105BC769B8Q34993393-C6AFDA04-D151-4E76-94D4-E8D763EF5CB0Q35147183-787A992C-319B-4F30-BF83-FEDC22E9094DQ35606180-B50844BB-14D0-4FC0-8C72-EC192BF254ADQ35752185-212EB3FA-4A30-4D80-B77F-D4E20F70A682Q35823652-95645CE4-5142-4FBC-8435-4AA1BF38DDD0Q35828434-BFFEDDD1-51DA-46E0-8E1A-4D78657A9785Q35854652-28B96310-D550-4E92-BEE5-21665662D974Q35887816-5479AEF8-AF17-41C0-8423-5F0CCDC139E1Q35915645-D067A54B-2240-42BF-9EC7-BC9D3A48D2AEQ35927832-4A5B09F9-AC27-4DF2-9FBF-194FB04194F9Q36090228-C8CFEB99-8DAA-4637-9964-EA22D59C57D4Q36106323-3102AA84-DCFC-4F87-89C5-0C0486121C9BQ36176486-9C2B7A0B-41A4-4C0C-B946-4B2DDBB41898Q36176499-4A464806-5C14-47A8-B77B-3FA2239B1351Q36247115-C07F7D54-3973-4D7C-9932-CC4821E1E243Q36370835-018740E0-D357-4B3D-98A4-F60B0107C713Q36506869-D4B5ADE5-329A-457E-85EE-2014E812DBAEQ36579398-BA5DF3D6-58A3-4045-A319-B7C9FF9F7176Q36933683-F907C2D5-93A1-46DB-8473-B32D6BA2D06CQ37216210-4E9A7429-2B25-480A-A594-14692637541AQ37271987-EAB3EC81-8026-4D1B-891A-B901C4F20E5CQ37396781-B4C93AB5-7EE2-4565-A30A-CEE40674B2A3Q37595794-1230B225-FAB5-42A4-A916-6173C7E82481Q38072364-49B9043E-599A-4E90-880D-B858AD7A5971Q38087533-55BCBBF1-2828-4EF1-8F9F-AFA80C6F2DC3Q38220272-53B537B8-3916-4415-B29A-FA0B13DD9F71Q38468985-30D9F209-2193-4A97-B89C-AFB6051DB232Q38520997-B6472858-A309-493F-8FB7-6BC1E8F3DAD8Q38563981-406FF518-2CB2-48BD-ADED-3D0BE2DDBE0F
P2860
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
CB2 receptor activation attenu ...... l ischemic/reperfusion injury.
@ast
CB2 receptor activation attenu ...... l ischemic/reperfusion injury.
@en
type
label
CB2 receptor activation attenu ...... l ischemic/reperfusion injury.
@ast
CB2 receptor activation attenu ...... l ischemic/reperfusion injury.
@en
prefLabel
CB2 receptor activation attenu ...... l ischemic/reperfusion injury.
@ast
CB2 receptor activation attenu ...... l ischemic/reperfusion injury.
@en
P2093
P2860
P1476
CB2 receptor activation attenu ...... al ischemic/reperfusion injury
@en
P2093
Doina Ganea
Jack Jallo
Martin W Adler
Ming Zhang
Ronald F Tuma
P2860
P356
10.1016/J.MVR.2009.03.005
P577
2009-03-28T00:00:00Z